Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].

Orvosi hetilap - 29 May 2011

Pár Alajos

Abstract excerpt

The review discusses the genetic polymorphisms involved in the pathogenesis of hepatitis C virus (HCV) infection, that may determine the outcome of disease. In this field earlier both certain major histocompatibility complex (MHC) alleles and some cytokine gene variants have also been studied. Recently, the genome-wide association study (GWAS) and targeted single nucleotide polymorphism (SNP) analysis have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, MHC Class I
Share to Genes, MHC Class II
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferons

Share to Interleukin-10

Share to Interleukins

Share to Lymphotoxin-alpha

Share to Pyrophosphatases

Source

Identifiers

PMID: 21565755
DOI: 10.1556/OH.2011.29113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic polymorphisms as predictors of response to antiviral treatment in chronic hepatitis C virus infection].PMID 21565755Read ↗

[Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].Semantic proximity Read ↗

[Role of IL-28B SNPs in the treatment and prognosis of HCV infection].Semantic proximity Read ↗

[Genome-wide association study on and the clinical application to chronic hepatitis C].Semantic proximity Read ↗

[IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].Semantic proximity Read ↗

Host genetic variants in the pathogenesis of hepatitis C.Semantic proximity Read ↗

Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.Semantic proximity Read ↗

Interleukin28B and inosine triphosphatase help to personalize hepatitis C treatment.Semantic proximity Read ↗

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.Semantic proximity Read ↗

Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C.Semantic proximity Read ↗

IL28B polymorphism -- predictive factor of HCV infected genotype 1 individuals to treatment response and management of therapy.Semantic proximity Read ↗

[Genetic variation of IL-28B is associated with treatment response of patients with chronic hepatitis C].Semantic proximity Read ↗

The impact of human gene polymorphisms on HCV infection and disease outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.